glp 16&1 GLP-1 Prescribing Is Rising — But Not Equally Across Populations First 90 Days on GLP-1

Im not trying to create panic or, you know, thats the other thing I get accused of, is You are just saying these horrible things to get likes and clicks on social media. Im like, I am sounding the alarm because this is the path that society is happy for us to head down and Im not signing up for this. I deserve BB: I mean, youre not Like thats so funny that that would be an accusation

Three things must be true before switching to this reduced frequency

Arch Osteoporos

Molecular basis for hormone recognition and activation of corticotropin-releasing factor receptors

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities (Zepbound)